PREVENTIVE ROLE OF ZINC CHLORIDE AGAINST TOXICITY OF CIPROFLOXACIN ON THE GROWING CARTILAGE OF WISTAR ALBINO RAT LITTER
Abstract
Objective: To assess the preventive role of zinc chloride on toxicity of ciprofloxacin administration inwistar albino rat litter. It was a Prospective experimental study. The study was carried out in thedepartment of Anatomy, Basic Medical Sciences Institute, Jinnah Postgraduate Medical Centre,Karachi, Pakistan during March 2002 to February 2003 one year study. Method: Ciprofloxacin andzinc chloride were administered to newly born albino rat litters separately and simultaneously at a doseof 20 mg/kg body weight and 1200 g/Kg body weight respectively, intraperitonealy twice daily from1–14 day after birth. The animals were sacrificed by deep ether anaesthesia. The fore and hind limbswere dis-articulated from the axial skeleton, soft tissue was removed and bones were fixed in 10%buffered formalin. Decalcification was done in 10% nitric acid and 10% formic acid changes. Afterparaplast embedding, 4m thick longitudinal sections of proximal & distal ends of long bones were cutby a rotary microtome. Routine staining with haemotoxylin and eosin was performed.Histomorphometery was done to measure the thickness of epiphyseal cartilage and was compared withsimilar values of the control animals. The results were statistically analyzed to evaluate the significance.Result: Our study revealed that ciprofloxacin administration in new born albino rat litter decreased thewidth of epiphyseal growth plate cartilage by 13.7±0.42 m, 10.43% in humerus and 6.6±1.2 m4.72% in femur as compared to control, whereas, simultaneous zinc chloride administration restrictedthe decrease to 1.27 m±SD in humerus and 2.05 m±SD in femur. Conclusion: Simultanous zincchloride administration minimized the epiphseal cartilage damage induced by ciprofloxacin in Wistaralbino rat litter.Keywords: Ciprofloxacin, Cartilage toxicity, Cartilage growth, Zinc chloride, Epiphyseal growthplate, Growth rate, Chondrocyte.References
Arcieri GM, Becker N, Esposito B, Griffith E, Heyd A,
Neumann C, et al.. Safety of intravenous ciprofloxacin. A
review. Am J Med 1989; 87(Supl. 5A): 92S–97S.
Katzung BG. Fluoroquinolones. In: Basic and clinical
pharmacology, 8th ed., New York, McGraw Hill, 2001;
p.797–801.
J Ayub Med Coll Abbottabad 2008;20(4)
http://www.ayubmed.edu.pk/JAMC/PAST/20-4/Channa.pdf 81
Davis H, Mc, Goodwin E, Green Reed T. Anaphylactoid
reactions reported after treat with ciprofloxacin. Ann In Med
;111:1041–3.
Schacht P, Arcieri G, Branotle J. Worldwide clinical data on
efficacy and safety of ciprofloxacin. Infection,
;16(1):S29–43.
Grasmick BK, Lehr VT, Sundareson AS. Fulminant hepatic
failure possibly related to ciprofloxacin. Ann Pharmacother,
;26:636–9.
Simpson J, Wastan AR, Mellersh A, Nelson CS, Dodd K.
Typhoid fever, ciprofloxacin and renal failure. Arch Dis
Child 1991;66:1083–4.
Greenber R N, Keenedy D J, Reilly P M, Luppen K L.
treatment of bones joint and soft tissue infection with oral
ciprofloxacin. Antimicrob Agent chemother, 1987;31:151–5.
Channa M.A., Janjua M.Z. Effects of cirprofloxacin on foetal
hepatocytes. J Pak Med Assoc. 2003;53:448–50.
Hooper D C, Wolfson J S, Swartz M N. Mechanism of action
and resistance to ciprofloxacin. Am J Med. 1987;82(S4):12–20.
Lewinson D, Harel Z, Shenzer P, Silbermann M, Hochberg
Z. Effect of thyroid Harmone and growth harmone on
recovery from hypothyroidsm of epiphyseal growth plate
cartilage and its adjacent bone. Endocrinology,
;124:937–45.
Arora NK. Are Fluoroquinolones safe in children?
Annotation Indian J Pediatr 1994;61:601–3.
Ames B N; Shingenga M K; and Hagen T M. Oxidants,
antioxidants and degenerative diseases of aging. Roc Natl
Acad Soci. 1993;90:7915–22.
MacDonald RS. The Role of Zinc in Growth and Cell
proliferation. J Nutr, 2000;130:1500S–1508S.
Shay NF, Mangian NF. Neurobiology of Zinc – influenced
eating behaviour. J-Nutr, 2000;130(5S Suppl):1493S–1499S.
S Ruth, Mac Donald. The Role of Zinc in growth and cell
proliferation. J Nutr 2000;130:1500S–1508S.
Rough R. Reproductive system. In: The mouse. 2nd ed.
Mineapolis: Burgress Pub Co, 1968; p.269–99.
Chang HH, Schwartz Z, Kaufman MH. Limb and other
postcranial skeletal defects induced by amniotic sac puncture
in mouse. J Anat, 1996;198:37–49.
Green E C. Anatomy of Rat. Philadelphia: American
philosophical society, 1968;Vol. XXVIII, 5–30.
Martindale W. The complete drug reference 33rd ed.
Sweetman SC. London, Chicago Pharmaceutical press.
:182–5.
Oteiza P L, Cuellar S; Lonnerdal B O. Influence of maternal
dietary Zinc intake on in vitro tubulin polymerization in
foetal rat brain. Teratol 1990;97–104.
Lori EK, Sulick K K. Experimental foetal alcohol syndrome
proposed pathogenic basis for a variety of associated facial
and Brain anamalies. Am J Gen Med, 1992;44:168–76.
Channa H.M.A., Ashfaque M, Mastoi S M, Qureshi M.A.
Effects of ciprofloxacin on growing cartilage in Albino rat
pups. J Ayub Med Coll Abbottabad 2006;18(3):50–4.
Bancroft J D; Stevens A. Theory and Practice of Histological
Techniques. 3rd ed. Edinburgh: Churchill Livingston, 1990;
pp. 88,112, 232, 503.
Bland M. Introduction of medical statistics. 1st ed. Oxford:
Oxford University press, 1987; p.165–87.
Schaad UB, Stoupis C, Wedgwood J, Tschaepeler H, vock
peter. Clinical radiologic and magnetic resonance monitoring
for skeletal toxicity in pediatric patients with cystic fibrosis
receiving a three-month course of ciprofloxacin. Pediatr
Infect. Dis J, 1991;10:723–9.
Stahlmann R. Children as a special population at riskquinolones as example for xenobiotic exhibiting skeletal
toxcity. Arch Toxicol, 2003;77(1): 7–11.
Stahlmann R, Lode H. Toxicity of quinolones. Drugs,
;58 Suppl 2:37–42.
Hickory W, Nanda R, Gatalanoto F A. Foetal skeletal
malformation associated with moderate zinc defficiency
during pregnancy. J Nutr; 1979;109:883–91.
Prasad A S. Discovery of human Zin deficiency and studies
in an experimental human model. Am J Clin Nutr;
;53:403–12.
Young B, Health J.W. Skeletal tissue. In: Wheater’s
Functional Histology. 4th ed., Edinburgh, Churchill
Livingston, 2000.
Published
Issue
Section
License
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
